179 related articles for article (PubMed ID: 17242561)
21. Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma.
Nishiyama Y; Yamamoto Y; Fukunaga K; Kimura N; Miki A; Sasakawa Y; Wakabayashi H; Satoh K; Ohkawa M
J Nucl Med; 2006 Apr; 47(4):633-8. PubMed ID: 16595497
[TBL] [Abstract][Full Text] [Related]
22. Comparison of [(18)F]FDG PET and (201)Tl SPECT in evaluation of pulmonary nodules.
Higashi K; Ueda Y; Sakuma T; Seki H; Oguchi M; Taniguchi M; Taki S; Tonami H; Katsuda S; Yamamoto I
J Nucl Med; 2001 Oct; 42(10):1489-96. PubMed ID: 11585862
[TBL] [Abstract][Full Text] [Related]
23. Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer.
Nishiyama Y; Yamamoto Y; Kimura N; Ishikawa S; Sasakawa Y; Ohkawa M
Ann Nucl Med; 2008 May; 22(4):245-50. PubMed ID: 18535874
[TBL] [Abstract][Full Text] [Related]
24. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size.
Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K
Ann Thorac Surg; 2005 Mar; 79(3):984-8; discussion 989. PubMed ID: 15734419
[TBL] [Abstract][Full Text] [Related]
25. Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis.
Kanegae K; Nakano I; Kimura K; Kaji H; Kuge Y; Shiga T; Zhao S; Okamoto S; Tamaki N
Ann Nucl Med; 2007 Aug; 21(6):331-7. PubMed ID: 17705012
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic performance of dual-time 18F-FDG PET in the diagnosis of pulmonary nodules: a meta-analysis.
Barger RL; Nandalur KR
Acad Radiol; 2012 Feb; 19(2):153-8. PubMed ID: 22104289
[TBL] [Abstract][Full Text] [Related]
27. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
Khalaf M; Abdel-Nabi H; Baker J; Shao Y; Lamonica D; Gona J
J Hematol Oncol; 2008 Sep; 1():13. PubMed ID: 18808716
[TBL] [Abstract][Full Text] [Related]
28. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
Uesaka D; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Fujibayashi Y; Okazawa H
J Nucl Med; 2008 Oct; 49(10):1606-12. PubMed ID: 18794269
[TBL] [Abstract][Full Text] [Related]
30. Shorter-time dual-phase FDG PET/CT in characterizing solid or ground-glass nodules based on surgical results.
Chiu CF; Lin YY; Hsu WH; Chen CY; Yeh JJ; Kao CH
Clin Imaging; 2012; 36(5):509-14. PubMed ID: 22920354
[TBL] [Abstract][Full Text] [Related]
31. [Fluorine-18 fluorodeoxyglucose uptake in patients with benign pulmonary nodules].
Yu CH; Wang T; Sun YE; Yao SL; Tian JH; Yin DY
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):90-2. PubMed ID: 16620664
[TBL] [Abstract][Full Text] [Related]
32. [Value of [18F]-FDG-PET/CT as a predictor of cancer in solitary pulmonary nodule].
Martins Rde C; Almeida SA; Siciliano AA; Landesmann MC; Silva FB; Franco CA; Fonseca LM
J Bras Pneumol; 2008 Jul; 34(7):473-80. PubMed ID: 18695792
[TBL] [Abstract][Full Text] [Related]
33. Improved discrimination between benign and malignant LDCT screening-detected lung nodules with dynamic over static
Ye Q; Wu J; Lu Y; Naganawa M; Gallezot JD; Ma T; Liu Y; Tanoue L; Detterbeck F; Blasberg J; Chen MK; Casey M; Carson RE; Liu C
Phys Med Biol; 2018 Sep; 63(17):175015. PubMed ID: 30095083
[TBL] [Abstract][Full Text] [Related]
34. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.
Dewan NA; Shehan CJ; Reeb SD; Gobar LS; Scott WJ; Ryschon K
Chest; 1997 Aug; 112(2):416-22. PubMed ID: 9266877
[TBL] [Abstract][Full Text] [Related]
35. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
36. Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region.
Reyes N; Onadeko OO; Luraschi-Monjagatta Mdel C; Knox KS; Rennels MA; Walsh TK; Ampel NM
Lung; 2014 Aug; 192(4):589-93. PubMed ID: 24801058
[TBL] [Abstract][Full Text] [Related]
37. Generation of parametric K
Wu J; Liu H; Ye Q; Gallezot JD; Naganawa M; Miao T; Lu Y; Chen MK; Esserman DA; Kyriakides TC; Carson RE; Liu C
Med Phys; 2021 Sep; 48(9):5219-5231. PubMed ID: 34287939
[TBL] [Abstract][Full Text] [Related]
38. Solitary pulmonary nodules differentiated by dynamic F-18 FDG PET in a region with high prevalence of granulomatous disease.
Huang YE; Lu HI; Liu FY; Huang YJ; Lin MC; Chen CF; Wang PW
J Radiat Res; 2012; 53(2):306-12. PubMed ID: 22374400
[TBL] [Abstract][Full Text] [Related]
39. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
Hellwig D; Graeter TP; Ukena D; Groeschel A; Sybrecht GW; Schaefers HJ; Kirsch CM
J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of primary pulmonary carcinoid tumors using FDG PET.
Erasmus JJ; McAdams HP; Patz EF; Coleman RE; Ahuja V; Goodman PC
AJR Am J Roentgenol; 1998 May; 170(5):1369-73. PubMed ID: 9574618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
